Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01698398
Other study ID # H-1-2012-092
Secondary ID
Status Completed
Phase N/A
First received October 2, 2012
Last updated February 10, 2014
Start date October 2012

Study information

Verified date October 2012
Source Rigshospitalet, Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: Ethics Commitee.
Study type Interventional

Clinical Trial Summary

The purpose of the study is to examine the relationship between working capacity (peak oxygen consumption) and pump speed of continuous flow left ventricular assist devices (CF-LVADs)in heart failure patients. The hypothesis is that it is possible to increase peak oxygen consumption by incrementally increasing CF-LVAD pumpspeed during exercise.

The study population will consist of severe heart failure patients with CF-LVADs treated at The Heart Centre of Copenhagen University Hospital Rigshospitalet.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date
Est. primary completion date January 2013
Accepts healthy volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- HeartMate II patients who underwent surgery and follow-up at The Heart Centre of Rigshospitalet.

- Heart failure in stable phase without the need for intravenous inotropic therapy.

- Ischemic and non-ischemic cardiomyopathy.

Exclusion Criteria:

- Severe aortic insufficiency.

Study Design

Allocation: Randomized, Masking: Double Blind (Subject, Investigator)


Related Conditions & MeSH terms


Intervention

Device:
Incremental pump speed of CF-LVAD.
Peak oxygen consumption with fixed versus incremental pump speed.

Locations

Country Name City State
Denmark Department of Cardiology, Copenhagen University Hospital, Rigshospitalet. Copenhagen.

Sponsors (1)

Lead Sponsor Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Exercise time (minutes), anerobic threshold. Day 1
Primary Peak oxygen consumption. ml oxygen/minute/kg Day 1
Secondary Working capacity. Watt Day 1
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT01238874 - Latin America Cardiac Resynchronization Therapy Study Phase 4
Completed NCT01851889 - Optimizing Continuous-flow Left Ventricular Assist Device Settings and Identification of Pump Malfunction - A Comparative Study of Echocardiography and Invasive Hemodynamics N/A